Alivus Life Sciences (BOM:543322) Total Stockholders Equity : ₹28,174 Mil (As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Alivus Life Sciences Total Stockholders Equity?

Alivus Life Sciences's Total Stockholders Equity for the quarter that ended in Mar. 2025 was ₹28,174 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Alivus Life Sciences's Book Value per Share for the quarter that ended in Mar. 2025 was ₹229.92. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Alivus Life Sciences's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.02.

Alivus Life Sciences Total Stockholders Equity Historical Data

The historical data trend for Alivus Life Sciences's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alivus Life Sciences Total Stockholders Equity Chart

Alivus Life Sciences Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Total Stockholders Equity

Get a 7-Day Free Trial

7,527.47

20,543.12

21,382.07

23,323.22

28,173.72

Alivus Life Sciences Quarterly Data
	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															23,323.22	-	25,384.80	-	28,173.72

Alivus Life Sciences (BOM:543322) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Alivus Life Sciences's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(28173.72	-	0)	/	122.537
	=	229.92

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Alivus Life Sciences's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(56.48	+	509.58)	/	28173.72
	=	0.02

Alivus Life Sciences Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Alivus Life Sciences's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Alivus Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alivus Life Sciences Ltd (BOM:543322) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

ALIVUS:India

Address

470, Cardinal Gracious Road, 4th Floor, OIA House, Andheri (East), Mumbai, MH, IND, 400 099

Website

https://www.alivus.com

Alivus Life Sciences Ltd, formerly Glenmark Life Sciences Ltd develops, manufactures, and supplies high-quality active pharmaceutical ingredients for cardiovascular disease, central nervous system disease, pain management, diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas.

Alivus Life Sciences Headlines

No Headlines